-transparent.png){kind=logo}
We reviewed the records of 37 patients with myasthenia gravis treated with azathioprine (n = 10) or cyclophosphamide (n = 27). All patients had received prednisone and anticholinesterase therapy, and most had undergone thymectomy prior to immunosuppressive therapy. Thirty patients (81%) responded to treatment. Both azathioprine and cyclophosphamide were found to be effective in the treatment of myasthenia gravis. The degree of improvement was more pronounced in patients with thymoma.
Related Publications
E Niakan, and
Y Harati, and
L A Rolak
November 1977,
The New England journal of medicine,
E Niakan, and
Y Harati, and
L A Rolak
January 1970,
Acta medica Academiae Scientiarum Hungaricae,
E Niakan, and
Y Harati, and
L A Rolak
June 1976,
Der Nervenarzt,
E Niakan, and
Y Harati, and
L A Rolak
January 2021,
Autoimmunity reviews,
E Niakan, and
Y Harati, and
L A Rolak
January 1981,
Annals of the New York Academy of Sciences,
E Niakan, and
Y Harati, and
L A Rolak
October 2015,
Biochemical pharmacology,
E Niakan, and
Y Harati, and
L A Rolak
April 1971,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
E Niakan, and
Y Harati, and
L A Rolak
December 1976,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
E Niakan, and
Y Harati, and
L A Rolak
February 2018,
Annals of the New York Academy of Sciences,
E Niakan, and
Y Harati, and
L A Rolak
April 1971,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
